Analytical Review on Raloxifene -An Estrogen Receptor Modulator in Different Pharmaceutical Formulations and Biological Fluids

Simple item page
dc.contributor.authorAshwini v. Gujar
dc.contributor.authorAnand B. Mundada
dc.contributor.authorAtul A. Shirkhedkar
dc.date.accessioned2025-12-17T09:26:34Z
dc.date.available2025-12-17T09:26:34Z
dc.date.issued2017-05-05
dc.description.abstractRaloxifene (RLX) is an oral selective estrogen receptor modulator (SERM). It is showing estrogenic action on bone and anti-estrogenic action on uterus and breast. An extensive literature has been published for analysis of RLX in different pharmaceutical formulations. This review article endeavor to provide the detail account on analytical methods for RLX and also validation details for its readers. It further helps to avoid costly chemicals and time consuming exercises for further investigation of RLX.
dc.identifier.issn2321-2217
dc.identifier.issn2321-2225
dc.identifier.otherhttps://doi.org/10.15415/jptrm.2017.51004
dc.identifier.urihttps://demodspace.chitkara.edu.in/handle/123456789/204
dc.language.isoen
dc.publisherChitkara University Publications
dc.subjectAnalytical Method
dc.subjectRaloxifene
dc.subjectRP-HPLC
dc.subjectHPTLC
dc.subjectValidation
dc.titleAnalytical Review on Raloxifene -An Estrogen Receptor Modulator in Different Pharmaceutical Formulations and Biological Fluids
dc.typeArticle

Files

Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
JPTRM Volume 5 Issue 1 004.pdf
Size:
592.38 KB
Format:
Adobe Portable Document Format
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed to upon submission
Description:
Download

Collections

JPTRM Vol. 5 No. 1 (May 2017)